$KNTE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kinnate Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kinnate Biopharma Inc.. Get notifications about new insider transactions in Kinnate Biopharma Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | KNTE | Kinnate Biopharma ... | MITCHELL DEAN J | Director | Option Exercise | A | 24.46 | 20,250 | 495,315 | 20,250 | |
| Jun 14 2021 | KNTE | Kinnate Biopharma ... | Smaldone Alsup Laurie | Director | Option Exercise | A | 24.46 | 20,250 | 495,315 | 20,250 | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 24,555 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 9,461 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 50,501 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 118,398 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 2,651,042 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 243,494 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 24,637 | 0 | 84,599 | 60 K to 84.6 K (+41.09 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 9,461 | 0 | 59,962 | 50.5 K to 60 K (+18.73 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 50,501 | 0 | 50,501 | 0 to 50.5 K | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 118,794 | 0 | 3,313,330 | 3.2 M to 3.3 M (+3.72 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 2,651,042 | 0 | 3,194,536 | 543.5 K to 3.2 M (+487.78 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 243,494 | 0 | 543,494 | 300 K to 543.5 K (+81.16 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 24,555 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 9,461 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 50,501 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 118,398 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 2,651,042 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 243,494 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 24,637 | 0 | 84,599 | 60 K to 84.6 K (+41.09 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 9,461 | 0 | 59,962 | 50.5 K to 60 K (+18.73 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 50,501 | 0 | 50,501 | 0 to 50.5 K | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 118,794 | 0 | 3,313,330 | 3.2 M to 3.3 M (+3.72 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 2,651,042 | 0 | 3,194,536 | 543.5 K to 3.2 M (+487.78 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 243,494 | 0 | 543,494 | 300 K to 543.5 K (+81.16 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 48,376 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 145,128 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 157,222 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 18,641 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 55,922 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 2,666,002 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 99,488 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 298,465 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | C | 0.00 | 6,347,893 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | C | 0.00 | 166,667 | 0 | 291,667 | 125 K to 291.7 K (+133.33 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | C | 0.00 | 500,001 | 0 | 875,001 | 375 K to 875 K (+133.33 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | C | 0.00 | 9,171,643 | 0 | 9,671,643 | 500 K to 9.7 M (+1,834.33 %) | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Option Exercise | A | 20.00 | 40,501 | 810,020 | 40,501 | ||
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Rome Michael E | Option Exercise | A | 20.00 | 40,501 | 810,020 | 40,501 | ||
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | P | 20.00 | 450,000 | 9,000,000 | 450,000 | 0 to 450 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | P | 20.00 | 300,000 | 6,000,000 | 300,000 | 0 to 300 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 125,000 | 2,500,000 | 125,000 | 0 to 125 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 125,000 | 2,500,000 | 125,000 | 0 to 125 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 375,000 | 7,500,000 | 375,000 | 0 to 375 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 375,000 | 7,500,000 | 375,000 | 0 to 375 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 500,000 | 10,000,000 | 500,000 | 0 to 500 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Tananbaum James B. | Buy | P | 20.00 | 500,000 | 10,000,000 | 500,000 | 0 to 500 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Foresite Capital Management IV ... | 10% Owner | Grant | A | 20.00 | 125,000 | 2,500,000 | 125,000 | 0 to 125 K |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Foresite Capital Management IV ... | 10% Owner | Grant | A | 20.00 | 375,000 | 7,500,000 | 375,000 | 0 to 375 K |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | Foresite Capital Management IV ... | 10% Owner | Grant | A | 20.00 | 500,000 | 10,000,000 | 500,000 | 0 to 500 K |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | P | 20.00 | 450,000 | 9,000,000 | 450,000 | 0 to 450 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | P | 20.00 | 300,000 | 6,000,000 | 300,000 | 0 to 300 K |
Page: 1